About Hacettepe University Medical Faculty; Department of Ophthalmology
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
5
Hacettepe University
2
Clinical Trials at Hacettepe University Medical Faculty; Department of Ophthalmology
During the past decade, Hacettepe University Medical Faculty; Department of Ophthalmology conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 3 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study Investigating the Safety and Efficacy of Lampalizumab Intravitreal Injections in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
2014-10-06
2018-01-23
Terminated
975
The Potential Role of Dietary Antioxidant Capacity on Age-Related Macular Degeneration
2015-07-01
2016-02-20
Completed
200
A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema (YOSEMITE)
2018-09-05
2021-09-03
Completed
940
A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (LUCERNE)
2019-03-11
2022-01-07
Completed
658
A Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Diabetic Macular Edema
2020-08-05
2023-08-18
Active, not recruiting
1,479
Advanced Glycation End Products Are Associated With Diabetic Macular Edema
2018-07-07
2019-01-10
Completed
90
A Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Neovascular Age-Related Macular Degeneration
2021-04-19
2024-08-09
Active, not recruiting
1,036
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Hacettepe University Medical Faculty; Department of Ophthalmology
According to Clinical.Site data, the most researched conditions in "Hacettepe University Medical Faculty; Department of Ophthalmology" are
"Diabetic Macular Edema" (3 trials), "Age Related Macular Degeneration" (1 trials), "Diabetes Mellitus, Type 2" (1 trials), "Geographic Atrophy" (1 trials) and "Neovascular Age-related Macular Degeneration" (1 trials). Many other conditions were trialed in "Hacettepe University Medical Faculty; Department of Ophthalmology" in a lesser frequency.
Clinical Trials Intervention Types at Hacettepe University Medical Faculty; Department of Ophthalmology
Most popular intervention types in "Hacettepe University Medical Faculty; Department of Ophthalmology" are "Drug" (5 trials), "Other" (3 trials), "Procedure" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.
The name of intervention was led by "Faricimab" (4 trials), "Sham Procedure" (4 trials), "Aflibercept" (2 trials), "Dietary habits and intake" (1 trials) and "Lampalizumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Hacettepe University Medical Faculty; Department of Ophthalmology
The vast majority of trials in "Hacettepe University Medical Faculty; Department of Ophthalmology" are
7 trials for "All" genders.
Clinical Trials Status at Hacettepe University Medical Faculty; Department of Ophthalmology
Currently, there are NaN active trials in "Hacettepe University Medical Faculty; Department of Ophthalmology".
undefined are not yet recruiting,
undefined are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Hacettepe University Medical Faculty; Department of Ophthalmology,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Hacettepe University Medical Faculty; Department of Ophthalmology, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".